Magenta Therapeutics Q3 EPS $(0.54) Down From $(0.49) YoY

Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.54) per share. This is a 10.2 percent decrease over losses of $(0.49) per share from the same period last year.

Benzinga · 11/13/2019 13:09

Magenta Therapeutics (NASDAQ:MGTA) reported quarterly losses of $(0.54) per share. This is a 10.2 percent decrease over losses of $(0.49) per share from the same period last year.